longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Aimei Health Tech

AFJK

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 92.97, within the reasonable range, cheaper than 39.19% of the time in the past 3 years, and the industry ranks 184/489, the industry Median 11.59.

92.97xP/E
$12.11Stock price
$0.13Earnings per share
92.97xP/E
Stock price$12.11Earnings per share$0.13

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
58.03x
Typical range
38.59x–227.45x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.59x
024487296

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.59x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
TPGUSTpg
97.96x337.78%$16.95B
FCRSUSFutureCrest Acquisition
89.24x--$367.82M
TLNCUSTalon Capital
88.19x--$347.27M
TVAUSTexas Ventures Acquisition III
81.22x--$317.40M
OTGAUSOTG Acquisition I
81.09x--$303.22M
MKLYUSMcKinley Acquisition
92.75x--$250.14M
SOCAUSSolarius Capital Acquisition
87.08x--$242.47M
TWLVUSTwelve Seas Investment III
81.71x--$236.13M
BMHLUSBluemount Holdings - B
84.78x--$110.25M
WSTNUSWestin Acquisition
91.82x--$81.76M
SSEAUSStarry Sea Acquisition
91.63x--$79.03M
KVACFUSKEEN VISION ACQUISITION CORPORATION
80.07x--$68.54M
UYSCUSUY Scuti Acquisition
93.21x--$57.43M
AFJKUSAimei Health Tech
92.97x--$38.34M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.